A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 175
Summary
- Conditions
- Duodenal Ulcer
- Gastric Ulcer
- Type
- Interventional
- Phase
- Phase 3
- Design
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01568385
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon